NDMS

CDA CHAIR IN DIABETES MANAGEMENT

PUBLICATIONS

Selected Articles and Editorials in Peer-reviewed Journals
(1991 – present)

2013
  • Harris, Stewart B.; Gerstein, Hertzel C.; Yale, Jean-François; Berard, Lori; Stewart, John; Webster-Bogaert, Susan M.; Tompkins, Jordan W. Can Community Retail Pharmacists and Diabetes Expert Support Facilitate Insulin Initiation by Family Physicians? Results of the AIM@GP Randomized Controlled Trial. BMC Health Services Research. 2013, 13:71
  • Maple-Brown, Louise J., Brimblecombe, Julie; Connelly, Philip W.; Harris, Stewart B.; Mamakeesick, Mary; Zinman, Bernard; O’Dea, Kerin; Hanley, Anthony J. Short Report: Complications. Similarities and Differences in Cardiometabolic Risk Factors among Remote Aboriginal Australian and Canadian Cohorts. Diabetes Research and Clinical Practice. Available online 9 January 2013. doi:pii: S0168-8227(12)00515-3. 10.1016/j.diabres.2012.12.017. [Epub ahead of print]
  • Teoh, Hwee; Després, Jean-Pierre; Dufour, Robert; Fichett, David H.; Goldin, Lianne; Goodman, Shaun G.; Harris, Stewart B.; Langer, Anatoly; Lau, David C.W.; Lonn, Eva M.; Mancini, G.B. John; McFarlane, Philip A.; Poirier, Paul; Rabasa-Lhoret, Rémi; Tan, Mary; Leiter, Lawrence A. Identification and Management of Patients at Elevated Cardiometabolic Risk at the Canadian Primary Care Level: How well are we doing? Canadian Journal of Cardiology (In press)
  • Leiter, Lawrence A.; Berard, Lori; Bowering, C. Keith; Cheng, Alice Y.; Dawson, Keith G.; Ekoé, Jean-Marie; Fournier, Carl; Goldin, Lianne; Harris, Stewart B.; Lin, Peter; Ransom, Thomas; Tan, Mary; Hwee, Teoh; Tsuyuki, Ross T.; Whitham, Dana; Woo, Vincent; Yale, Jean-François; Langer, Anatoly. Type 2 Diabetes Mellitus Management in Canada: Is it Improving? Can J Diabetes (In press)
  • Gough, Stephen; Harris, Stewart B.; Woo, Vincent; Davies, Melanie. Insulin Degludec: Overview of a Novel Ultra Long-acting Basal Insulin. Diabetes, Obesity and Metabolism (In press)
  • Kayaniyil, Sheena; Harris, Stewart B.; Retnakaran, Ravi; Vieth, Reinhold; Knight, Julia A.; Gerstein, Hertzel C.; Perkins, Bruce A.; Zinman, Bernard; Hanley, Anthony J. Prospective Association of 25(OH)D with Metabolic Syndrome. Clinical Endocrinology (In press)
2012
  • Teoh H, Camelon KM, Gilbert RE, Harris SB, et al. Assessment and treatment of cardiometabolic risk in adults at risk for or with type 2 diabetes mellitus. Can J Diabetes.Dec 36(6):320-326, 2012
  • Richardson M, Thind A, Harris SB, Choid TH.  Exploring the factors associated with specialist referral for patients with type 2 diabetes: are we referring those in greatest need? Can J Diabetes. 2012;36(4):165-169.
  • Ley SH, Harris SB, Connelly PW, et al. Utility of non-high density lipoprotein cholesterol in assessing incident type 2 diabetes risk. Diabetes Obes Metab. 2012;14(9):821-825.
  • Dyck RF. Naqshbandi Hayward M; Harris, SB.  Prevalence, determinants and co- morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study. BMC Nephrology. Jul 13(1):57, 2012.
  • Liu S, Shah B, Naqshbandi M, Tran V, Harris S. Short Report: Complications. Increased rates of adverse outcomes for gestational diabetes and pre-pregancy diabetes in on-reserve First Nations women in Ontario, Canada . Diabetic Med. Aug 29(8):e180-e183, 2012.
  • Maple-Brown LJ, Cunningham J, Zinman B, Mamakeesick M; Harris SB, et al.  Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of indigenous cohorts with diabetes in Australia and Canada.; Cardiovasc r Diabetology. Mar 28, 11:30, 2012
  • Retnakaran R, Ye C, Hanley AJ, Harris SB, Zinman B. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes Obes Metab. 2012;14(1):91-93.
  • Chatterjee A, Bhattacharrya O, Fitchett DH, Teoh H, Harris SB, Leiter LA. Managing cardiometabolic risk in primary care: A summary of the 2011 consensus statement. Can Fam Phys. 2012: 50:389-393.
  • Naqshbandi-Hayward M, Kuzmina E, Dannenbaum D, Torrie J, Huynh J, Harris SB. Room for improvement in diabetes care among First Nations in Northern Quebec (Eeyou Istchee): reasonable management of glucose but poor management of complications. Int J Circumpolar Health. 2012:71:18418.
2011
  • Bhattacharyya OK, Rasooly IR, Naqshbandi M, Estey EA, Esler J, Toth E, Macaulay AC, Harris SB. Challenges to the provision of diabetes care in First Nations communities: results from a national survey of healthcare providers in Canada. BMC Health Serv Res. 2011;11:283. doi:10.1186/1472-6963-11-283.
  • Pottie K, Greenaway C, Feightner J, and coauthors of the Canadian Collaboration for Immigrant and Refugee Health. Evidence-based clinical guidelines for immigrants and refugees. Can Med Assoc J. 2011;183(12):E824-E925.
  • Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective associations of vitamin D with beta-cell function and glycemia: the PROMISE (PROspective Metabolism and ISlet cell Evaluation) cohort study. Diabetes. 2011;60:2947-2953.
  • He M, Harvey E, Harris SB, et al. Case Study 5: Addressing childhood obesity through a community-based strategy to screen and engage high-risk migrant families – families in action: a global village pediatric diabetes prevention resource. Public Health Agency of Canada. Available at: http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/rhd-rds-2011/case5-cas5-eng.php
  • Campbell NRC, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris SB. Hypertension in people with type 2 diabetes. Update on pharmacologic management. Can Fam Phys. 2011;57(9):997-1002.
  • Glazier R, Harris SB, Tompkins J, et al. Number of HbA1c tests unrelated to quality of diabetes control: an electronic medical record data linkage study. Diabetes Res Clin Pract. 2011;93(1):e37-e40.
  • Retnakaran R, Qi Y, Harris SB, Hanley AJ, Zinman B. Changes over time in glycemic control, insulin sensitivity and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Diabetes Care. 2011;34(7) :1601-1604.
  • Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GBJ, McFarlane PA, Ross R, Teoh H, Verma S, and Working Group. Cardiometabolic risk in Canada: A detailed analysis and position paper by the Cardiometabolic Risk Working Group. Can J Cardiol. 2011;27(2):e1-e33.
  • Leiter LA, Fitchett DH, Gilbert RE, Gupta M, Mancini GBJ, McFarlane PA, Ross R, Teoh H, Verma S, and Working Group. Identification and management of Cardiometabolic Risk in Canada: A position paper by the Cardiometabolic Risk Working Group (executive summary). Can J Cardiol. 2011;27(2):124-131.
  • He M, Piché L, Kurtz J, Beynon C, Harris SB. Screen-related sedentary behaviours of school-aged children: principals’ and teachers’ perspectives. Health Educ J.2011;70(1):32-38.
  • Naqshbandi M, Harris SB, Macaulay A, Comeau J. Lessons learned in using community-based participatory research to build a national diabetes collaborative in Canada. Progress in community health partnerships: research, education, and action.Community Health Partnerships: Research, Education, and Action. 2011; Winter 5(4):405-415.
  • Harris SB, Naqshbandi M, Bhattacharyya O, Hanley AJG, Elser J, Zinman B; CIRCLE Network Investigators. Major gaps in diabetes clinical care among Canada’s First Nations: Results of the CIRCLE study. Diab Res Clin Pract. 2011;92:272-279.
  • Ley S, Hegele RA, Harris SB, Mamakeesick M, Cao H, Connelly PW, et al. HNF1A G319S variant, active cigarette smoking and incident type 2 diabetes in Aboriginal Canadians: A population-based epidemiological study. BMC Med Genet. 2011;12(1). doi:10.1186/1471-2350-12-1.
  • Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA. Gerstein HC, et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and non-traditional components. J Clin Endocrinol Metab. 2011;96(1):168-175.
  • Mottola MF, Sopper MM, Doxtator L, Big-Canoe K, Prapavessis H, Harris SB, Hanley A. Capacity-building and participatory research development of a community-based nutrition and exercise lifestyle intervention program (NELIP) for pregnant and post-partum Aboriginal women: information gathered from talking circles. Int Indigenous Policy J. 2011;2(1):Article 8. Available at: http://ir.lib.uwo.ca/iipj/vol2/iss1/8
2010
  • Harris SB, Glazier RH, Tompkins JW, Wilton AS, Chevendra V, et al. Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study. BMC Health Serv Res. 2010;10:347. doi:10.1186/1472-6963-10-347.
  • Harris SB, Kapor J, Lank CN, Willan AR, Houston T. Clinical inertia in insulin-requiring type 2 diabetes patients in family practice. Can Fam Phys. 2010;56:e418-e424.
  • Zinman B, Harris SB, Neuman J, Gerstein HC, Retnakara R, Raboud J, et al. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study. Lancet. 2010;376(9735):103-111.
  • Bhattacharyya OK, Harris SB, Zwarenstein M, Barnsley J. Controlled trial of an intervention to improve cholesterol management in diabetes in remote Aboriginal communities. Int J Circumpolar Health. 2010;69(4):333-343.
  • Ley SH, Hegele RA, Connelly PW, Harris SB, Mamakeesick M, Cao H, et al. Assessing the association of HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: A population-based epidemiological study. Cardiovasc Diabetol. doi: 10.1186/1475-2840-9-39.
  • Tompkins JW, Luginaah IN, Booth GL, Harris SB. The geography of diabetes in London, Canada: The need for local level policy for prevention and management.Int J Environment Res Public Health. 2010;7(5):2407-2422. doi: 10.3390/ijerph7052407.
  • Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Ying Q, Gerstein HC, Perkins B, Harris SB, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk of type 2 diabetes. Brief report. Diabetes Care. 2010;33(6):1379-1381.
  • Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, et al. Association of apolipoprotein B with incident type 2 diabetes in an Aboriginal Canadian population. Clin Chem. 2010;56(4):666-670.
  • He M, Li E, Harris SB, Huff MW, Yau CY, Anderson G. The Canadian global village reality: a look at anthropometric surrogate cutoffs and metabolic abnormalities among East Asian, South Asian and European descendants. Can Fam Phys. 2010;56(5):3174-182.
  • Hanley AJB, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B. Association of hematological parameters with insulin resistance and beta-cell dysfunction in non-diabetic subjects: The PROspective Metabolism and Islet Cell Evaluation (PROMISE) Cohort. J Clin Endocrinol Metab. 2009;94(10):3824-2832.
  • Braga MB, Casanova A, Teoh H, Dawson KG, Gerstein HC, Fitchett D, Harris SB, et al. Treatment gaps in the management of cardiovascular risk factors in high-risk patients with type 2 diabetes in Canada (DRIVE). Can J Cardiol. 2010;26(6):297-302.
  • Mottola MF, Giroux I, Gratton R, Hammond J, Hanley A, Harris SB, et al. Nutrition and exercise prevents excess weight gain in pregnant overweight women. Med Sci Sports Exercise. 2010;42(2):265-272.
  • He M, Piché L, Beynon C, Harris S. Screen-related sedentary behaviors: children’s and parents’ attitudes, motivation and practices. J Nutr Educ Behav. 2010;42(1):17-25.
  • He M, Piché L, Clarson CL, Callaghan C, Harris SB. Childhood overweight & obesity management: a national perspective of primary health care providers’ views, practices, perceived barriers and needs. Paediatr Child Health. 2010;15(7):419-426.
2009
  • Ley SH, Harris SB, Mamakeesick M, et al. Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community. CMAJ. 2009;180(6):617-624.
  • Biderman A, Noff E, Harris SB, Friedman N, Levy A. Treatment satisfaction of diabetic patients: What are the contributing factors? Fam Pract. 2009;26(2):102-108.
2008
  • Harris SB (Member, Steering Committee). Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):S1-S201.
  • Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Global complication rates of type 2 diabetes in indigenous peoples: A comprehensive review. Diabetes Res Clin Pract. 2008;82(1):1-17.
  • Ho L, Gittelsohn J, Sharma S, Cao X, Treuth M, Rimal R, Ford E, Harris SB. Food-related behavior, physical activity, and dietary intake in First Nations – a population at high risk for diabetes. Ethn Health. 2008;13(4):335-349.
  • Ho L, Gittelsohn J, Rimal R, Treuth M, Sharma S, Rosecrans A, Harris SB. An integrated multi-institutional diabetes prevention program improves knowledge and healthy food acquisition in northwestern Ontario First Nations. Health Educ Behav. 2008;35(4):561-573.
  • Ley SH. Harris SB, Connelly PW, et al. Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: The Sandy Lake Health and Diabetes Project. Diabetes Care. 2008;31(7):1410-1415.
  • Terry AL, Thorpe CF, Giles G, Brown JB, Harris SB, et al. Implementing electronic health records: Key factors in primary care. Can Fam Physician. 2008;54(5):730-736.
  • Harris SB, Yale, J-F, Dempsey E, Gerstein HC. Can family physicians help patients initiate basal insulin therapy successfully? Randomized trial of patient-titrated insulin glargine compared with standard oral therapy: Lessons for family practice from the Canadian INSIGHT trial. Can Fam Physician. 2008;54(4):550-558.
  • Salsberg J, Louttit S, McComber AM, Fiddler R, Naqshbandi M, Receveur O, Harris SB, et al. Knowledge, capacity and readiness: Translating successful experiences in community-based participatory research for health promotion. Pimatisiwin: J Indigenous Aboriginal Community Health. 2008;5(2):125-150.
2007
  • Houlden R, Ross S, Harris S, Yale J-F, Sauriol, L, Gerstein HC. Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes: the Canadian INSIGHT Study. Diabetes Res Clin Pract. 2007;78(2):254-258.
  • Rosecrans A, Gittelsohn J, Ho LS, Harris SB, Naqshbandi M, Sharma S. Process evaluation of a multi-institutional community-based program among First Nations. Health Educ Res. 2008;23(2):272-286.
  • Harris SB, Leiter LA, Yale J-F, Chiasson J-L, Kleinstiver P, Sauriol L. Out-of-pocket costs of managing hyperglycemia and hypoglycemia in patients with type 1 diabetes and insulin-treated type 2 diabetes. Can J Diabetes. 2007;31(1):25-33.
2006
  • Zinman B, Harris SB, Gerstein HC, et al. Preventing type 2 diabetes using combination therapy: design and methods of the Canadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Diabetes Obes Metab. 2006;8(5):531-537.
  • McPherson R, Frohlich J, Fodor G, Genest J, Grover S, Habib R, Harris, S, et al. Canadian Cardiovascular Society position statement – recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006;22(11):913-927.
  • Leiter LA, Genest J, Harris SB, et al; for the Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Dyslipidemia in adults with diabetes. Can J Diabetes. 2006;30(3):230-240.
  • Harris SB, Worrall G, Macaulay A, et al. Diabetes management in Canada: Baseline results of the Group Practice Diabetes Management Study. Can J Diabetes. 2006;30(2):131-137.
  • Gerstein HC, Yale J-F, Harris SB, Issa M, Stewart JA, Dempsey E. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med. 2006;23(7):736-742.
  • Liu J, Hanley AJG, Young TK, Harris SB, Zinman B. Lifestyle variables, non-traditional cardiovascular risk factors, and the metabolic syndrome in an Aboriginal Canadian population. Obesity. 2006;14(3):500-508.
  • Liu J, Hanley AJG, Young TK, Harris SB, Zinman B. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond). 2006;30(4):669-676.
  • Pollex RL, Hanley AJG, Zinman B, Harris SB, Khan HMR, Hegele RA. Metabolic Syndrome in Aboriginal Canadians: prevalence and genetic associations. Atherosclerosis. 2006;184(1):121-129.
  • Pollex RL, Hanley AJG, Zinman B, Harris SB, Hegele RA. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian Aboriginal population. Int J Obes (Lond). 2006;30(3):484-491.
  • Ho LS, Gittelsohn J, Harris SB, Ford E. Development of an integrated diabetes prevention program with First Nations in Canada. Health Promot Int. 2006;21(2):88-97.
2005
  • Leiter LA, Harris SB, Chiasson J-L, Edwards L, O’Neill MC, Van DM. Efficacy and safety of rosiglitazone as monotherapy or in combination with metformin in primary care settings. Can J Diabetes. 2005;29(4):384-392.
  • Leiter LA, Yale J-F, Chiasson J-L, Harris SB, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes. 2005;29(3):186-192.
  • Majumdar SR, Johnson JA, Bowker SL, Booth GL, Dolovich L, Ghali W, Harris SB, et al. A Canadian consensus for the standardized evaluation of quality improvement interventions in type 2 diabetes. Can J Diabetes. 2005; 29(3):220-229.
  • Woo V, Harris SB, Houlden RL; for the Clinical & Scientific Section, Canadian Diabetes Association. Canadian Diabetes Association position paper on antipsychotic medications and associated risk of weight gain and diabetes. Can J Diabetes. 2005;29(2):111-112.
  • Retnakaran R, Hanley AJG, Connelly PW, Harris SB, Zinman B. Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths. CMAJ. 2005;173(8):885-889.
  • Pollex RL, Hanley AJG, Zinman B, Harris SB, Khan HMR, Hegele RA. Synergism between mutant HNF1A and the metabolic syndrome in new onset Oji-Cree type 2 diabetes. Diabet Med. 2005;22(11):1510-1515.
  • Saksvig BI, Gittelsohn J, Harris SB, Hanley AJG, Valente TW, Zinman B. A pilot school-based healthy eating and physical activity intervention improves diet, food knowledge and self-efficacy for native Canadian children. J Nutr. 2005;135(10):2392-2398.
  • Retnakaran R, Hanley AJG, Connelly PW, Harris SB, Zinman B. Elevated C-reactive protein in Native Canadian children: An ominous early complication of childhood obesity. Diabetes Obes Metab. 2005;8(5):483-491.
  • Harris SB, Ekoé J-M, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes in Canada Evaluation study). Diabetes Res Clin Pract. 2005;70(1):90-97.
  • Harris SB, Leiter LA, Webster-Bogaert S, Van DM, O’Neill C. Teleconferenced educational detailing: An innovative diabetes CME program for primary care physicians. J Contin Educ Health Prof. 2005;25(2):87-97.
  • Hanley AJG, Harris SB. Mamakeesick M, et al. Complications of type 2 diabetes among Aboriginal Canadians: Prevalence and associated risk factors. Diabetes Care. 2005;28(8):2054-2057.
  • Stewart M, Marshall JN, Østbye T, Brown JB, Harris SB, Feightner JW, et al. Effectiveness of case-based on-line learning of evidence based practice guidelines. Fam Med. 2005;37(2):131-138.
  • Harris SB. Managing diabetes. Recommendations and caveats [editorial]. Can Fam Physician. 2005;51(May):637-639.
2004
  • Harris SB, Petrella RJ, Lambert-Lanning A, Leadbetter W, Cranston L. Lifestyle management for type 2 diabetes. Are family physicians ready and willing? Can Fam Physician. 2004;50(May):1235-1243.
  • Harris SB, Lank CN. Recommendations from the Canadian Diabetes Association: 2003 Guidelines for prevention and management of diabetes and related cardiovascular risk factors. Can Fam Physician. 2004;50(Mar):425-429.
2003
  • Hanley AJG, Harris SB, Mamakeesick M, et al. Complications of type 2 diabetes among Aboriginal Canadians: Increasing the understanding of prevalence and risk factors. Can J Diabetes. 2003;27(4):455-463.
  • Macaulay AC, Harris SB, Lévesque L, et al. Primary prevention of type 2 diabetes: Experiences of 2 Aboriginal communities in Canada. Can J Diabetes. 2003;27(4):464-475.
  • (Chair, Expert Committee). Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S156.
  • Harris SB, Petrella RJ, Leadbetter W. Lifestyle interventions for type 2 diabetes. Relevance for clinical practice. Can Fam Physician. 2003;49(Dec):1618-1625.
  • Hanley AJG, Connelly PW, Harris SB, Zinman B. Adiponectin in a Native Canadian population experiencing rapid epidemiological transition. Diabetes Care. 2003;26(12):3219-3225.
  • Harris SB, Stewart M, Brown, JB, et al. Type 2 diabetes in family practice: Room for improvement. Can Fam Physician. 2003;49(Jun):778-785.
  • Hegele RA, Zinman B, Hanley AJG, Harris SB, Barrett PH, Cao H. Genes, environment and Oji-Cree type 2 diabetes. Clin Biochem. 2003;36(3):163-170.
2002
  • Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M. The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002;19(4):344-349.
  • Hanley AJG, McKeown-Eyssen G, Harris SB, et al. Association of parity with risk of type 2 diabetes and related metabolic disorders. Diabetes Care. 2002;25(4):690-695.
  • Harris SB, Zinman B, Hanley AJG, et al. The impact of diabetes on cardiovascular disease risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract. 2002;55(2):165-173.
2001
  • Hanley AJG, McKeown-Eyseen G, Harris SB, et al. Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care. 2001;24(7):1240-1247.
  • Kriska AM, Hanley AJG, Harris SB, Zinman B. Physical activity, physical fitness, and glucose concentrations in an isolated Native Canadian population experiencing rapid lifestyle change. Diabetes Care. 2001;24(10):1787-1792.
2000
  • Harris SB, Webster-Bogaert S, Lillie D, Lank CN. A model for the dissemination of clinical practice guidelines – the Canadian Diabetes Association experience. Can J Diabetes Care. 2000;24(2):64-69.
  • Hegele RA, Cao H, Hanley AJG, Zinman B, Harris SB, Anderson CM. Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians. Diabetes Care. 2000;23(6):775-778.
  • Hegele RA, Hanley AJG, Zinman B, Harris SB, Anderson CM. Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree. J Hum Genet. 2000;45(3):184-187.
  • Hanley AJG, Harris SB, Gittelsohn J, Wolever TMS, Saksvig B, Zinman B. Overweight among children and adolescents in a Native Canadian community: Prevalence and associated factors. Am J Clin Nutr. 71(3):693-700.
  • Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJG, Anderson CM. Gender, obesity, hepatic nuclear factor-1a G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree. Int J Obes Relat Metab Disord. 2000;24(8):1062-1064.
  • Hegele RA, Cao H, Harris SB, Hanley AJG, Zinman B, Connelly PW. The private hepatic nuclear factor-1a G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. Arterioscler Thromb Vasc Biol. 2000;20(1):217-222.
  • Harris SB, Zinman B. Primary prevention of type 2 diabetes in high risk populations [editorial]. Diabetes Care. 2000;23(7):879-881.
1999
  • Hegele RA, Cao H, Harris SB, Hanley AJG, Zinman B. The hepatic nuclear factor-1a G319S variant is associated with early onset type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 1999;84(3):1077-1082.
  • Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-a concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84(1):272-278.
1998
  • Harris SB, Macaulay AC. Diabetes management: New evidence-based recommendations. Highlights of the 1998 Canadian clinical practice guidelines. Canadian Diabetes Association. Can Fam Physician. 1998;44(Nov):2465-2472.
  • Harris SB, Meltzer SJ, Zinman B. New guidelines for the management of diabetes: A physician’s guide. CMAJ. 1998;159(8):973-978.
  • Harris SB. What works? Success stories in type 2 diabetes mellitus. Diabet Med. 1998;15(suppl 4):S20-S23.
  • Harris SB, Glazier R, Eng K, McMurray L. Disease patterns among Canadian aboriginal children. Study in a remote rural setting. Can Fam Physician. 1998;44(Sep):1869-1877.
  • Caulfield LE, Harris SB, Whalen-Brough EA, Sugamori ME. Maternal nutritional status, diabetes and risk of macrosomia among Native Canadian women. Early Hum Dev. 1998;50(3):293-303.
  • Gittelsohn J, Wolever TMS, Harris SB, Harris-Giraldo R, Hanley AJG, Zinman B. Specific patterns of food consumption and preparation are associated with diabetes and obesity in a Native Canadian community. J Nutr. 1998;128(3):541-547.
  • Harris SB, Macaulay AC. Taking on diabetes. Family doctors on the front lines of the battle against diabetes [editorial]. Can Fam Physician. 1998;44(Nov):2345-2349.
1997
  • Hanley AJG, Harris SB, Gao XJ, Kwan J, Zinman B. Serum immunereactive leptin concentrations in a Canadian aboriginal community with high rates of NIDDM. Diabetes Care. 1997;20(9):1408-1415.
  • Harris SB, Caulfield LE, Sugamori ME, Whalen-Brough EA, Henning B. The epidemiology of diabetes in pregnant Native Canadians: A risk profile. Diabetes Care. 1997;20(9):1422-1425.
  • Harris SB, Gittelsohn J, Hanley AJG, et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care. 1997;20(1):185-187.
1996
  • Gittelsohn J, Harris SB, Thorne-Lyman AL, Hanley AJG, Barnie A, Zinman B. Body image concepts differ by age and sex in an Ojibway-Cree community in Canada. J Nutr. 1996;126:2990-3000.
  • Gittelsohn J, Harris SB, Burris KL, et al. Use of ethnographic methods for applied research on diabetes among Ojibway-Cree Indians in Northern Ontario. Health Educ Q. 1996;23(3):365-382.
  • Harris SB, Perkins BA, Whalen-Brough EA. Non-insulin-dependant diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario. Can Fam Physician. 1996;42(May):869-876.
1991 – 1995
  • Hanley AJG, Harris SB, Gittelsohn J, Wolever TMS, Barnie A, Zinman B. The Sandy Lake Health and Diabetes Project: Design, methods and lessons learned. Chronic Dis Canada. 1995;16(4):149-155.
  • Gittelsohn J, Harris SB, Whitehead S, et al. Developing diabetes interventions in an Ojibwa-Cree community in Northern Ontario: Linking qualitative and quantitative data. Chronic Dis Canada. 1995;16(4):157-163.
  • Fox C, Harris SB, Brough EA. Diabetes among Native Canadians in northwestern Ontario: 10 Years later. Chronic Dis Canada. 1994;15(3):92-96.

Top of Page

Dr. Stewart B. Harris, CDA Chair in Diabetes Management

Stewart B. Harris,
MD, MPH, FCFP, FACPM
CDA Chair in
Diabetes Management